The effects of nicotine on cognition are dependent on baseline performance

European Neuropsychopharmacology

Volumn 24, Issue 7, 2014, Pages 1015-1023

  Niemegeers, Peter ^a,b   Dumont, Glenn J H ^a,b   Quisenaerts, Charel ^a   Morrens, Manuel ^a,c   Boonzaier, Julia ^a,b   Fransen, Erik ^a   de Bruijn, Ellen R A ^a,d   Hulstijn, Wouter ^a,e   Sabbe, Bernard G C ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Psychiatric Hospital Duffel   (Belgium)

^c Psychiatric Hospital Broeders Alexianen   (Belgium)

^d LEIDEN UNIVERSITY   (Netherlands)

^e RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Cognition; Elderly; Nicotine

Indexed keywords

NICOTINE; NICOTINE GUM; PLACEBO;

ADULT; AGING; ARTICLE; ATTENTION; COGNITION; CONTINUOUS PERFORMANCE TEST; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGIT SYMBOL SUBSTITUTION TEST; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EMOTIONALITY; FEMALE; HUMAN; MALE; MOTOR CONTROL; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; STEREOTYPY; TASK PERFORMANCE; VISION; VISUAL MEMORY; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY; WRITING; ADOLESCENT; AGE; AGED; DOSE RESPONSE; DRUG EFFECTS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; REACTION TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ATTENTION; COGNITION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NICOTINE; REACTION TIME; YOUNG ADULT;

EID: 84902319820     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.03.011     Document Type: Article

References (34)

1. Ammons R.B. Effect of distribution of practice on rotary pursuit "hits". J. Exp. Psychol. 1951, 41:17-22.
2. Baglio F., Castelli I., Alberoni M., Blasi V., Griffanti L., Falini A., Nemni R., Marchetti A. Theory of mind in amnestic mild cognitive impairment: an FMRI study. J. Alzheimer[U+05F3]s Dis. 2012, 29:25-37.
3. Birks J. Cholinesterase inhibitors for Alzheimer[U+05F3]s disease. Cochrane Database Syst Rev. 2006, 1:CD005593.
4. Brody A.L., Mandelkern M.A., London E.D., Olmstead R.E., Farahi J., Scheibal D., Jou J., Allen V., Tiongson E., Chefer S.I., Koren A.O., Mukhin A.G. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch. Gen. Psychiatry 2006, 63:907-915.
5. Castelli I., Baglio F., Blasi V., Alberoni M., Falini A., Liverta-Sempio O., Nemni R., Marchetti A. Effects of aging on mindreading ability through the eyes: an fMRI study. Neuropsychologia 2010, 48:2586-2594.
6. Christensen H. What cognitive changes can be expected with normal ageing?. Aust. N. Z. J. Psychiatry 2001, 35:768-775.
7. Cools R., D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol. Psychiatry 2011, 69:e113-e125.
8. Cornblatt B.A., Risch N.J., Faris G., Friedman D., Erlenmeyer-Kimling L. The continuous performance test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988, 26:223-238.
9. Dani J.A., Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Ann. Rev. Pharmacol. Toxicol. 2007, 47:699-729.
10. Docx L., Morrens M., Bervoets C., Hulstijn W., Fransen E., De Hert M., Baeken C., Audenaert K., Sabbe B. Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr. Scand. 2012, 126:256-265.
11. Drag L.L., Bieliauskas L.A. Contemporary review 2009: cognitive aging. J. Geriatr. Psychiatry Neurol. 2010, 23:75-93.
12. Dumont G.J., van Hasselt J.G., de Kam M., van Gerven J.M., Touw D.J., Buitelaar J.K., Verkes R.J. Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. J. Psychopharmacol. (Oxford, England) 2011, 25:478-489.
13. Heishman S.J., Kleykamp B.A., Singleton E.G. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology 2010, 210:453-469.
14. Jasinska, A.J., Zorick, T., Brody, A.L., Stein, E.A., 2013. Dual role of nicotine in addiction and cognition: A review of neuroimaging studies in humans. Neuropharmacology. pii: S0028-3908(13)00072-5. [Epub ahead of print] PubMed PMID: 23474015; PubMed Central PMCID: PMC3710300. http://dx.doi.org/10.1016/j.neuropharm.2013.02.015.
15. Levin E.D., McClernon F.J., Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 2006, 184:523-539.
16. Min S.K., Moon I.W., Ko R.W., Shin H.S. Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers. Psychopharmacology 2001, 159:83-88.
17. Mitsis E.M., Cosgrove K.P., Staley J.K., Bois F., Frohlich E.B., Tamagnan G.D., Estok K.M., Seibyl J.P., van Dyck C.H. Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiol. Aging 2009, 30:1490-1497.
18. Mitsis E.M., Cosgrove K.P., Staley J.K., Frohlich E.B., Bois F., Tamagnan G.D., Estok K.M., Seibyl J.P., Van Dyck C.H. [123I]5-IA-85380 SPECT imaging of beta2-nicotinic acetylcholine receptor availability in the aging human brain. Ann. N. Y. Acad. Sci. 2007, 1097:168-170.
19. Morrens M., Hulstijn W., Lewi P., Sabbe B. Bleuler revisited: psychomotor slowing in schizophrenia as part of a catatonic symptom cluster. Psychiatry Res. 2008, 161:121-125.
20. Morrens M., Hulstijn W., Lewi P.J., De Hert M., Sabbe B.G. Stereotypy in schizophrenia. Schizophr. Res. 2006, 84:397-404.
21. Morrens M., Hulstijn W., Van Hecke J., Peuskens J., Sabbe B.G. Sensorimotor and cognitive slowing in schizophrenia as measured by the Symbol Digit Substitution Test. J. Psychiatr. Res. 2006, 40:200-206.
22. Newhouse P., Kellar K., Aisen P., White H., Wesnes K., Coderre E., Pfaff A., Wilkins H., Howard D., Levin E.D. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology 2012, 78:91-101.
23. Newhouse P.A., Potter A., Singh A. Effects of nicotinic stimulation on cognitive performance. Curr. Opin. Pharmacol. 2004, 4:36-46.
24. Pardini M., Nichelli P.F. Age-related decline in mentalizing skills across adult life span. Exp. Aging Res. 2009, 35:98-106.
25. Quisenaerts C., Morrens M., Hulstijn W., de Boer P., Timmers M., Sabbe B., de Bruijn E.R. Acute nicotine improves social decision-making in non-smoking but not in smoking schizophrenia patients. Front. Neurosci. 2013, 7:197.
26. Quisenaerts C., Morrens M., Hulstijn W., de Bruijn E., Timmers M., Streffer J., De la Asuncion J., Dumont G., Sabbe B. The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?. Psychopharmacology 2014, 231:543-550.
27. Quisenaerts C., Morrens M., Sabbe B. The nicotine receptor as target for the improvement of cognitive symptoms in schizophrenia. Tijdschr. voor Psychiatr. 2013, 55:415-425.
28. Rolinski M., Fox C., Maidment I., McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson[U+05F3]s disease dementia and cognitive impairment in Parkinson[U+05F3]s disease. Cochrane Database Syst Rev. 2012, 3:CD006504.
29. Sarter M., Parikh V. Choline transporters, cholinergic transmission and cognition. Nat. Rev. Neurosci. 2005, 6:48-56.
30. Sivan A.B. Benton Visual Retention Test: Manual. The Psychological Corporation 1992, Harcourt Brace & Company, San Antonio, TX, USA.
31. Vellante M., Baron-Cohen S., Melis M., Marrone M., Petretto D.R., Masala C., Preti A. The Reading the Mind in the Eyes test: systematic review of psychometric properties and a validation study in Italy. Cogn Neuropsychiatry 2013, 18(4):326-354.
32. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised 1981, The Psychological Corporation, San Antonio.
33. Wechsler D. Wechsler Adult Intelligence Scale-III 1997, The Psychological Corporation, San Antonio.
34. White H.K., Levin E.D. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology 2004, 171:465-471.